BILATERAL AVASCULAR NECROSIS OF FEMORAL HEAD FOLLOWING COVID-19 INFECTION: CASE SERIES

Fakruddin Shershah Kammar; Chandrashekar Mudgal; Madhuchandra Ramanand; Akash Kumar

doi:10.5937/sanamed18-43995

Fakruddin Shershah Kammar Department of physical medicine and rehabilitation (PMR), Karnataka Institute of medical sciences, Hubli
Chandrashekar Mudgal Department of orthopaedics, Karnataka Institute of medical sciences, Hubli
Madhuchandra Ramanand Department of orthopaedics, Karnataka Institute of medical sciences
Akash Kumar Department of orthopaedics, Karnataka Institute of medical sciences, Hubli

DOI: https://doi.org/10.5937/sanamed18-43995

Keywords: Avascular necrosis (AVN), sedimentation rate of erythrocytes (ESR), C-reactive proteins (CRP), White blood cells (WBC), Steroid-induced AVN femoral head (SANFH)

Abstract

Introduction: Despite having a substantial impact on survivors' mobility and leading to morbidity, musculoskeletal involvement was the post-COVID-19 infection sequelae area that received the least attention in the literature. Reviewing the COVID-19 histories of patients who visited a tertiary health center, the research is aimed at finding an association between COVID-19 infection and avascular femoral head necrosis, a condition brought on by insufficient blood flow. Avascular necrosis of the femoral head is a condition characterized by a restricted range of motion, pain, and disturbance of gait. It is brought on by insufficient blood flow. Case reports: We discussed several examples in which COVID-19 caused individuals to develop bilateral femoral head necrosis. When COVID-19 infection is the only factor present, and corticosteroids are used to treat it, avascular necrosis of the femoral head may become more prevalent. Detecting avascular necrosis of the femoral head in its early stages, hip MRI might reduce the patient's disability and need for continuous treatment. Conclusion: Early identification and treatment of AVN patients reduce the need for surgery and the chance of disabilities.

References

1. Kordzadeh-Kermani E, Khalili H, Karimzadeh I. Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19). Future microbiol. 2020;15(13):1287-305. doi: 10.2217/fmb-2020-0110.

2. Agarwala SR, Vijayvargiya M, Pandey P. Avascular necrosis as a part of ‘long COVID-19’. BMJ Case Reports CP. 2021;14(7):e242101. doi: 10.1136/bcr-2021-242101.

3. Malizos KN, Karantanas AH, Varitimidis SE, Dailiana ZH, Bargiotas K, Maris T. Osteonecrosis of the femoral head: etiology, imaging, and treatment. Eur J Radiol. 2007;63(1):16-28. doi: 10.1016/j.ejrad.2007.03.019.

4. Sultan AA, Mohamed N, Samuel LT, Chughtai M, Sodhi N, Krebs VE, et al. Classification systems of hip osteonecrosis: an updated review. Int orthop. 2019;43(5):1089-95. doi: 10.1007/s00264-018-4018-4.

5. Dhanasekararaja P, Soundarrajan D, Kumar KS, Pushpa BT, Rajkumar N, Rajasekaran S. Aggressive presentation and rapid progression of osteonecrosis of the femoral head after COVID-19. Indian J Orthop. 2022;56(7):1259-67. doi: 10.1007/s43465-022-00635-2.

6. Becker RC. COVID-19-associated vasculitis and vasculopathy. J Thromb Thrombolysis. 2020;50(3):499-511. doi: 10.1007/s11239-020-02230-4.

7. Jia J, Feng X, Xu W, Yang S, Zhang Q, Liu X, et al. MiR-17-5p modulates osteoblastic differentiation and cell proliferation by targeting SMAD7 in non-traumatic osteonecrosis. Exp Mol Med. 2014;46(7):e107. doi: 10.1038/emm.2014.43.

8. Uysal A, Uysal ME. Bilateral avascular necrosis of the femoral head after COVID-19 infection: a case report. Med J West Black Sea 2022;6(2): 235-8.doi: 10.29058/mjwbs.1054040

9. Daltro G, Franco BA, Veiga D, Faleiro T, Lima V, Vitório F et al. Osteonecrosis development post Covid-19 infection. J Regen Biol Med. 2021;3(5):1-8. DOI: 10.37191/Mapsci-2582-385X-3(5)-087